The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis

OBJECTIVES: To investigate the efficacy and safety of Bevacizumab (Bev) used in combination with paclitaxel and carboplatin (PC), compared with PC alone in patients with advanced non-small-cell lung cancer (NSCLC). MATERIALS AND METHODS: We searched the PubMed, EMBASE, Cochrane Central Register of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Shiqian, Hong, Yuanduo, Liu, Tingting, Wu, Na, Ye, Zhijia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865694/
https://www.ncbi.nlm.nih.gov/pubmed/29581868
http://dx.doi.org/10.18632/oncotarget.23657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865694/
https://www.ncbi.nlm.nih.gov/pubmed/29581868
http://dx.doi.org/10.18632/oncotarget.23657

Ejemplares similares